Shandra Eisenga Human Cell and Tissue Product Safety Act
Sponsor

Full profile: /officials/M001194
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
1 cosponsor on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2025-06-24
Source: Congress.gov
Committee Activity
Currently in
- Senate Committee on Health, Education, Labor, and PensionsReferred To · 2025-06-24
- House Committee on Energy and CommerceReported By · 2025-06-12
Previously
- House Committee on Energy and CommerceMarkup By · 2025-04-29
- House Committee on Energy and CommerceReferred To · 2025-02-06
Plain-English Summary
Shandra Eisenga Human Cell and Tissue Product Safety Act This bill establishes civil penalties for violations of regulations governing the donation and handling of human cell and tissue products. It also requires the Food and Drug Administration (FDA) to report on the regulation of these products and to provide related information to stakeholders. ( Human cell and tissue products are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.) Specifically, the bill establishes civil penalties for violations of the FDA’s regulations on donor eligibility and current good tissue practice for manufacturing and distributing human cell and tissue products. Also, the bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion on the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and report to Congress with recommendations. The bill also requires the FDA to support the development of educational materials for health care professionals regarding organ, tissue, and eye donations and related topics. Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group (a working group within the FDA) and best practices for obtaining a recommendation from them about human cell and tissue products. Also, annually for three years, the FDA must publish on its website information on inquiries submitted to the Tissue Reference Group and FDA registrations and inspections regarding human cell and tissue manufacturers.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HRES1626Supporting the designation of the week of October 18 through 24, 2026, as "National Chemistry Week".Referred to Committee · 2026-10-15
- HR2306Adams Memorial-Great American Heroes ActPassed House · 2026-09-30
- HRES1570Marking the eighth anniversary of the unjust imprisonment of Dr. Gulshan Abbas by the Government of the People's Republic of China, condemning the use of transnational repression to retaliate against the exercise of free speech in the United States, and calling for her immediate and unconditional release.Referred to Committee · 2026-09-21
- HRES1526Expressing support for the designation of the week of September 11 through September 17, 2026, as "Patriot Week".Referred to Committee · 2026-09-10